Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
ARRA OS Recovery Act 2009 Limited Competition: Comparative Effectiveness Delivery System Demonstration Grants (R18)
Purpose.
This AHRQ Funding Opportunity Announcement (FOA), supported by funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites Research Demonstration and Dissemination Grant (R18) applications from organizations to conduct
demonstrations of (1) broad strategies and/or specific interventions for improving care by redesigning care delivery, or (2) strategies and interventions for improving care by redesigning payment.
(For examples and definitions of terms, see below, Objectives of this Funding Opportunity and Nature of this Funding Opportunity.) The demonstrations will aim to achieve major improvements in care quality (including clinical outcomes and other dimensions), improve access to care, reduce disparities, or improve population-based measures of health outcomes.
The demonstration will address issues related to HHS priorities, including those of Medicare and Medicaid.
In specifying its requirements for using ARRA funds in support of Comparative Effectiveness Research (CER), the Department of Health and Human Services (HHS) adopts the definition of CER as the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat, and monitor health conditions in real world settings.
HHS added that interventions compared may include medications, procedures, medical and assistive devices and technologies, diagnostic testing, behavioral change, and delivery system strategies.
The current FOA concentrates primarily on delivery system strategies, which in turn may affect other types of interventions.
In formulating its requirements related to CER, HHS drew on the recommendations of the Federal Coordinating Council for CER and on the 100 priority topics identified by the Institute of Medicine (IOM) in its 2009 report, Initial National Priorities for Comparative Effectiveness Research http://www.nap.edu/catalog/1264 8. html
This AHRQ Funding Opportunity Announcement (FOA), supported by funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites Research Demonstration and Dissemination Grant (R18) applications from organizations to conduct
demonstrations of (1) broad strategies and/or specific interventions for improving care by redesigning care delivery, or (2) strategies and interventions for improving care by redesigning payment.
(For examples and definitions of terms, see below, Objectives of this Funding Opportunity and Nature of this Funding Opportunity.) The demonstrations will aim to achieve major improvements in care quality (including clinical outcomes and other dimensions), improve access to care, reduce disparities, or improve population-based measures of health outcomes.
The demonstration will address issues related to HHS priorities, including those of Medicare and Medicaid.
In specifying its requirements for using ARRA funds in support of Comparative Effectiveness Research (CER), the Department of Health and Human Services (HHS) adopts the definition of CER as the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat, and monitor health conditions in real world settings.
HHS added that interventions compared may include medications, procedures, medical and assistive devices and technologies, diagnostic testing, behavioral change, and delivery system strategies.
The current FOA concentrates primarily on delivery system strategies, which in turn may affect other types of interventions.
In formulating its requirements related to CER, HHS drew on the recommendations of the Federal Coordinating Council for CER and on the 100 priority topics identified by the Institute of Medicine (IOM) in its 2009 report, Initial National Priorities for Comparative Effectiveness Research http://www.nap.edu/catalog/1264 8. html
Related Programs
Recovery Act Comparative Effectiveness Research AHRQ
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Agency for Health Care Research and Quality
Estimated Funding: $12,000,000
Office: Agency for Health Care Research and Quality
Estimated Funding: $12,000,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-013.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized).
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-013.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2010-02-19
Application Due Date:
2010-04-07
Archive Date:
2010-05-07
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
